Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PerkinElmer Inc.

www.perkinelmer.com

Latest From Merck Research Laboratories

PDUFA VI: 'Building Trust' Is Theme Of FDA-Industry Negotiations

Major achievements of latest drug user fee agreement include focus on drug development cycle, more review time and pilot programs, FDA and industry reps tell DIA meeting.

FDA Drug Review

Appointments: Eli Lilly, Alexion, Actelion, Polyphor, Constellation, Bone Therapeutics and Allied Minds

This week's roundup includes the announced retirement of Lilly's CFO, high-level appointments by Alexion Pharmaceuticals, Actelion and Constellation, and board elections by Wilson Therapeutics, Bone Therapeutics and Atlantic Healthcare.

BioPharmaceutical Appointments

Appointments: Bayer, Mustang, Modus, GammaDelta, Poxel, Metrion and Renova.

This week's roundup includes CEO appointments by various companies including Mustang Bio, GammaDelta and Modus Therapeutics and other high-level appointments by Bayer, Renova, Metrion and Poxel.

Appointments BioPharmaceutical

Appointments: IFPMA, Myokardia, ABPI, Mission Therapeutics, F2G, Arquer Diagnostics and Innovative Medicines Canada

This week's roundup includes top level updates from AstraZeneca and executive appointments by Myokardia, Asceneuron and Arquer Diagnostics.

Appointments BioPharmaceutical
See All

Company Information

Advertisement
Advertisement
UsernamePublicRestriction

Register